Literature DB >> 4348965

In vivo studies with collagenase from Pseudomonas aeruginosa.

B Diener, L Carrick, R S Berk.   

Abstract

An extracellular protease from Pseudomonas aeruginosa having collagenase activity was assayed in vivo. The lethality of the enzyme for white female mice was determined by use of intravenous, intraperitoneal, intranasal, and subcutaneous routes, respectively. The collagenase exhibited the following 72-hr mean lethal dose values: intranasally, 55 collagenase units; intraperitoneally, 148 collagenase units; and intravenously, 288 collagenase units. In the concentrations tested, no lethality was obtained when the subcutaneous route was employed. Gross and microscopic studies revealed that the collagenase was capable of eliciting a variety of tissue responses in mice depending upon its route of administration. Intranasal instillation resulted in confluent pulmonary hemorrhage, whereas intraperitoneal injections resulted in severe abdominal hemorrhage with foci on the intestinal serosa. Intravenous injections elicited abdominal hemorrhage and petechial hemorrhage with focal necrosis of the lungs, whereas subcutaneous injections resulted in necrotic, ulcerating lesions.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4348965      PMCID: PMC422662          DOI: 10.1128/iai.7.2.212-217.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Automatic analysis of tissue culture proteins with stable Folin reagents.

Authors:  B ZAK; J COHEN
Journal:  Clin Chim Acta       Date:  1961-09       Impact factor: 3.786

2.  Mechanism of corneal destruction by pseudomonas proteases.

Authors:  E FISHER; J H ALLEN
Journal:  Am J Ophthalmol       Date:  1958-11       Impact factor: 5.258

3.  Occurrence of serious bacterial infections since introduction of antibacterial agents.

Authors:  M FINLAND; W F JONES; M W BARNES
Journal:  J Am Med Assoc       Date:  1959-08-29

4.  Significance of selective vasculitis and the "bone-marrow" syndrome in Pseudomonas septicemia.

Authors:  W MARGARETTEN; H NAKAI; B H LANDING
Journal:  N Engl J Med       Date:  1961-10-19       Impact factor: 91.245

Review 5.  Management of pseudomonas keratitis.

Authors:  P C Hessburg
Journal:  Surv Ophthalmol       Date:  1969-07       Impact factor: 6.048

6.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

Authors:  A L Shapiro; E Viñuela; J V Maizel
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

7.  In vivo studies with a toxic fraction of Pseudomonas aeruginosa.

Authors:  G Meinke; R S Berk
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

8.  Collagenolytic activity of bacteria.

Authors:  F A Waldvogel; M N Swartz
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

9.  PARTIAL PURIFICATION OF THE EXTRACELLULAR HEMOLYSIN OF PSEUDOMONAS AERUGINOSA.

Authors:  R S BERK
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

10.  In Vivo Studies with the Partially Purified Protease (Elastase) from Pseudomonas aeruginosa.

Authors:  G Meinke; J Barum; B Rosenberg; R Berk
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

View more
  18 in total

Review 1.  Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease.

Authors:  D J Harrington
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.

Authors:  L W Heck; K Morihara; W B McRae; E J Miller
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa.

Authors:  R S Berk; D Brown; I Coutinho; D Meyers
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases.

Authors:  L Gray; A Kreger
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

5.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

6.  Toxic activity against alveolar macrophages of products of Pseudomonas aeruginosa isolated from respiratory and non-respiratory sites.

Authors:  A H Al-Dujaili
Journal:  J Hyg (Lond)       Date:  1976-10

7.  Reduced virulence of Pseudomonas aeruginosa grown in the presence of benzalkonium chloride.

Authors:  F W Adair; H L Liauw; S G Geftic; J Gelzer
Journal:  J Clin Microbiol       Date:  1975-02       Impact factor: 5.948

Review 8.  Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery.

Authors:  Aaron Dolor; Francis C Szoka
Journal:  Mol Pharm       Date:  2018-05-16       Impact factor: 4.939

9.  Simple method for collagenase determination in 38 Pseudomonas aeruginosa strains.

Authors:  G Wellisch; E Cohen; Z Cahane; J Horowitz
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

10.  Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.

Authors:  D E Ohman; S J Cryz; B H Iglewski
Journal:  J Bacteriol       Date:  1980-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.